Supporting
resilient
founders

Our goal is to be the first person the entrepreneur reaches out to in times of trouble and joy.

We are a sector agnostic early-stage investor that wants to partner with founders from the very beginning of their journey and support them throughout their growth. Our team has global experience in building and scaling companies both as founders and in various CxO roles. We invest in ambitious and determined teams that can one day become industry leaders.

Follow us on Twitter

Investment highlights

Charlotta Topelius and Niklas Sandler Topelius
Seed round

CurifyLabs

CEO: Charlotta Topelius
Founders: Charlotta Topelius, Niklas Sandler Topelius
Tuomo Riekki
Andreas Stenman
Angel round

Focal

CEO: Tuomo Riekki
Founders: Tuomo Riekki, Andreas Stenman
Johannes Salmisaari
Henrik Helenius
Seed round

Droppe

CEO: Johannes Salmisaari
Founders: Johannes Salmisaari, Henrik Helenius
Anttoni Aniebonam
Verneri Jäämuru
Frans Lehmusvaara
Angel round

Veri / Human Engineering

CEO: Anttoni Aniebonam
Founders: Anttoni Aniebonam, Verneri Jäämuru, Frans Lehmusvaara
Mari Tenhunen
Jyrki Savela
Lauri Kurki
Seed round

Timegate Instruments

CEO: Mari Tenhunen
Founders: Mari Tenhunen, Lauri Kurki, Jyrki Savela
Aaro Isosaari
Karolus Sariola
Angel round

Flowrite

CEO: Aaro Isosaari
Founders: Aaro Isosaari, Karolus Sariola
Matti Rönkkö
Seed round

Cooler Future

CEO: Matti Rönkkö
Founders: Matti Rönkkö, Moaffak Ahmed
Pia Henrietta Moon
Angel round

Carbo Culture

CEO: Pia Henrietta Moon
Founders: Pia Henrietta Moon, Christopher Carstens
Tim Koschella
Puneet Gupta
Servesh Jain
Seed round

Kayzen

CEO: Tim Koschella
Founders: Tim Koschella, Puneet Gupta, Servesh Jain

Portfolio events

Charlotta Topelius and Niklas Sandler Topelius
Lifeline Ventures
Seed round

CurifyLabs

Through modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, on-demand manufacture of medicines, customized to provide safe and effective treatment for all patients.

Read more

CurifyLabs

Through modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, on-demand manufacture of medicines, customized to provide safe and effective treatment for all patients. CurifyLabs is committed to automating and streamlining the drug compounding process enabling personalization of drug treatments to better fit the need of each specific patient. Our goal is to maximize the personalization potential of drug treatments for better patient outcomes with our pharmaceutical 3D printing concept. The technology is based on over 10 years of extensive academic research conducted by Professor Niklas Sandler Topelius and his research group. Today CurifyLabs serves pharmacies on several European markets with a talented team of pharmaceutical formulation developers, software engineers and quality control experts.

CEO: Charlotta Topelius

Founders: Charlotta Topelius, Niklas Sandler Topelius

Visit website
2021
Founded
2022
Lifeline Ventures
Seed round
6/2022
Ville Leppälä
Ville Lehto
Lifeline Ventures
Seed round

Huuva

Huuva, the platform powering virtual restaurants, has raised €1,05 million in funding and opened its first kitchen. With the help of this backing, Huuva is setting its sights already on the wider Helsinki area and, later in the fall, Central Europe.

Read more

Huuva

Huuva is the next-generation virtual food court for commercial restaurants looking to optimize their food delivery business. In a nutshell, Huuva operates technology enabled kitchens in the most optimal locations for delivery food around cities. Restaurants can focus on the cooking, while Huuva takes care of everything else. This helps restaurants minimize costs and maximize returns from delivery food, while serving delicious dishes to eaters every single time.

CEO: Ville Leppälä
Founders: Ville Leppälä, Ville Lehto

Visit website
2021
Founded
2021
Lifeline Ventures
Angel round
2022
Lifeline Ventures
Seed round
02/2022
Tuomo Riekki
Andreas Stenman
Lifeline Ventures
Angel round

Focal

Focal is a SaaS collaboration app for marketers and designers, combining project management and creative asset collaboration in one platform. Focal makes it easy to get from idea to launch by streamlining and automating early stages of the marketing campaign lifecycle, from briefs to final deliverables.

Read more

Focal

Focal is a SaaS collaboration app for marketers and designers, combining project management and creative asset collaboration in one platform. Focal makes it easy to get from idea to launch by streamlining and automating early stages of the marketing campaign lifecycle, from briefs to final deliverables.

CEO: Tuomo Riekki
Founders: Tuomo Riekki, Andreas Stenman

Visit website
2021
Founded
2022
Lifeline Ventures
Angel round
01/2022
Jakob Wikström
Alexander Silén
Lifeline Ventures
Seed round

Mobal

Mobal has raised a €2 million seed round. With the backing, Mobal is setting its sights on the international market, providing globally leading location marketing services and software solutions. The new funding marks the beginning of large-scale development, not only to serve their clients better but also increase their workforce exponentially.


Mobal

Business listings are replacing websites, and typically, it is the last thing a business owner will spend time optimizing. Mobal.io helps businesses get discovered online by providing the best services and SaaS solutions to help businesses ensure that their online presence is as accurate and effective as possible.

CEO: Jakob Wikström
Founders: Jakob Wikström & Alexander Silén

Visit website
2020
Founded
2021
Lifeline Ventures
Seed round
11/2021

Compliance

AIFM license

We are a registered alternative investment fund manager (AIFM). We are supervised by the Finnish Financial Supervisory Authority.

FVCA membership

Lifeline Ventures is a member of the Finnish Venture Capital Association (FVCA) and follows the association’s rules and guidelines.

Reporting and valuation guidelines

We follow Invest Europe’s Investor Reporting Guidelines in our investor reporting. The valuation of the portfolio is done in accordance with the International Private Equity and Venture Capital Valuation (IPEV) Guidelines.

Our funds

Lifeline Ventures Fund I Ky (€28.8m)
Lifeline Ventures Fund II Ky (€17.1m)
Lifeline Ventures Fund III Ky (€57.0m)
Lifeline Ventures Fund IV Ky (€130.0m)

Funds’ investors

Pension companies: 25%
Funds of funds: 22%
Family offices: 22%
Public sector: 16%
Other asset managers: 4%
General Partners: 4%
Insurance companies: 3%
Private individuals: 3%
Foundations: 1%

Finland: 94%
Rest of Europe: 5%
Outside of Europe: 1%

Contact for media

Timo Ahopelto, timo@lifelineventures.com

Responsible investment policy

Lifeline Ventures invests responsibly. We follow our responsible investment policy which means that not only economic aspects, but also environmental, social and governance (ESG) issues/opportunities as well as sustainability risks/opportunities are taken into consideration in investment decisions, due diligence and ownership activities. No investments are made if a potential portfolio company fails to meet the requirements of Lifeline Ventures’ responsible investment policy and there is no plan on how to address the ESG issues and sustainability risks. Where appropriate or deemed necessary, external advisors will be used for additional due diligence relating to ESG and sustainability risks. The evaluation of ESG and sustainability risks/opportunities is done on case-by-case basis and we focus on the matters that are relevant to the potential portfolio company and its operating environment. Sustainability risks mean environmental, social or governance events or conditions that, if they occur, could cause an actual or a potential material negative impact on the value of the investment.

Lifeline Ventures will not make any investments in companies focusing on any of the following: tobacco, nuclear energy, pornography, arms industry or arms trading, animal or human cloning, or gambling industry. In addition, we will not invest in companies or founders which we determine to operate unethically. We see ESG-related opportunities as a potential source of competitive advantage for a portfolio company and thus they have a positive impact on the investment decision.

Lifeline Ventures does not currently consider adverse impacts of investment decisions on sustainability factors within the meaning of Article 4(1)(a) of the EU Regulation 2019/2088 on sustainability‐related disclosures in the financial services sector. We act in accordance with the Article 4(1)(b) of the EU Regulation in question for the time being as there is uncertainty surrounding the content of the obligation set out in Article 4(1)(a) and because our adverse impact is likely to be very small or not measurable taking into account the size, the nature and scale of our activities and the types of financial products we make available. Lifeline Ventures intends to consider such adverse impacts when further information on the requirements is available.